TopNews + Font Resize -

IDMA in assn with NSF Health Sciences, UK to organise Advanced Programme in Pharmaceutical Quality Management
Our Bureau, Mumbai | Friday, September 15, 2017, 08:00 Hrs  [IST]

The Indian Drug Manufacturers Association (IDMA) in association with NSF Health Sciences, UK is organising the first ever international education program - Advanced  Programme in Pharmaceutical Quality Management (APPQM) on September 26, 2017 at the Acharya College Campus, Bengaluru.

It includes five intensive modules each of 4 days duration scheduled every 8 weeks. Each module will be assessed by written examination. Successful candidates will be awarded an internationally recognized Certification from NSF and IDMA.

This unique, world-class program will provide the training needed to comply with GMP regulations. Course modules are very interactive and led by world-class, international experts. Participants will learn best-in-class practices and apply them in practical problem solving and real-life case studies, they will learn by doing.

In addition to module-specific content, participants will be provided with a deep understanding of simplification, risk-based decision making and advanced problem solving skills. This advanced education programme covers best industry and regulatory practices presented by world-class tutors with 35 years of hands-on experience. It is designed for companies who aspire to be the best and who want a secure future.

Martin Lush, Global VP, NSF Health Sciences would be spearheading this training programme.

This program will help quality control heads of Indian pharma companies enhance audit-readiness and implement compliance in areas of good manufacturing practices (GMP), quality assurance, documentation, data integrity and quality management system (QMS).

Introduction of APPQM is a major breakthrough for Indian pharma industry as technical and QA professionals in India are trained in GMP compliance only through experience and therefore need a formal education in pharmaceutical quality management of international standards. The programme encompasses ICH, WHO And USFDA requirements and best industry practices.

As there was no formal training program in India on taking corrective measures timely raised by regulatory authorities like US FDA, UK MHRA and other regulators on GMP deficiencies, Data Integrity issues, among others, the training programme was conceptualised for QA personnel to train and recognise them as qualified persons on the lines of courses conducted in UK by NSF, UK.

Comments

Pradeep Awasthi Sep 15, 2017 11:53 AM
In the recent times Indian pharmaceutical landscape is escalating very fastly,For retaining higher profitability,Indian pharma companies are highly depending on exports towards western countries,but the poor growth of Indian pharma companies in the year of 2016/2017,was the resultant of exports which has been restricted by European countries and US because of quality related issues with Indian manufacturing facilities.

Therefore bringing International education programme to facilitate Indian companies Quality professional to comply with good manufacturing practice and International quality standards is the need of hour,This programme will greatly help to get equipped quality management professional of big Indian pharma companies and future concern company in improving their management system and skills related problem solving,risk management and tough decision making to comply with GMP standards.

Post Your Comment

 

Enquiry Form